TY  - JOUR
AU  - Wieringa, Gijsbert
AU  - Queraltó, Josep
AU  - Homšak, Evgenija
AU  - Jassam, Nuthar
AU  - Cavalier, Etienne
AU  - Svinarov, Dobrin
AU  - Krleža, Jasna L
AU  - Christou, Spyroula
AU  - Pikner, Richard
AU  - Larsen, Trine Rennebod
AU  - Tomberg, Karel
AU  - Linko-Parvinen, Anna
AU  - Sapin, Vincent
AU  - Baum, Hannsjorg
AU  - Kroupis, Christos
AU  - Bagoly, Zsuzsa
AU  - Costelloe, Sean
AU  - Sciacovelli, Laura
AU  - Stasulans, Janis
AU  - Vitkus, Dalius
AU  - Meunier, Danielle
AU  - Solnica, Bogdan
AU  - Reguengo, Henrique
AU  - Mambet, Cristina
AU  - Kovac, Gustav
AU  - Krhin, Blaž
AU  - Ohlson, Mats
AU  - Buhagiar, Gerald
AU  - Simundic, Ana-Maria
TI  - A proposed common training framework for specialists in laboratory medicine under EU directive 2013/55/EC (The recognition of professional qualifications).
JF  - CLINICAL CHEMISTRY AND LABORATORY MEDICINE
J2  - CLIN CHEM LAB MED
VL  - 59
PY  - 2021
IS  - 3
SP  - 505
EP  - 512
PG  - 8
SN  - 1434-6621
DO  - 10.1515/cclm-2020-1504
UR  - https://m2.mtmt.hu/api/publication/31868045
ID  - 31868045
AB  - European Union (EU) Directive 2013/55/EC (The Recognition of Professional qualifications) allows Member States to decide on a common set of minimum knowledge, skills and competences that are needed to pursue a given profession through a Common Training Framework. To be adopted the framework must combine the knowledge, skills and competences of at least one third of the Member States. Professionals who have gained their qualifications under a Common Training Framework will be able to have these recognised automatically within the Union. The backbone of the European Federation of Clinical Chemistry and Laboratory Medicine's (EFLM) proposed Common Training Framework for non-medical Specialists in Laboratory Medicine is outlined here. It is based on an Equivalence of Standards in education, training, qualifications, knowledge, skills, competences and the professional conduct associated with specialist practice. In proposing the recognition of specialist practice EFLM has identified 15 EU Member States able to meet Equivalence and in whom the profession and/or its training is regulated (an additional EU Commission requirement). The framework supports and contributes to the Directive's enabling goals for increasing professional mobility, safeguarding consumers and ensuring a more equitable distribution of skills and expertise across the Member States. It represents EFLM's position statement and provides a template for professional societies and/or competent authorities to engage with the EU Commission.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Káplár, Miklós
AU  - Sweni, Shah
AU  - Kulcsár, Júlia
AU  - Cogoi, Barbara
AU  - Esze, Regina
AU  - Somodi, Sándor
AU  - Papp, Mária
AU  - Oláh, László
AU  - Magyar, Mária Tünde
AU  - Szabó, Katalin Judit
AU  - Kovács, Katalin Réka
AU  - Hársfalvi, Jolán
AU  - Paragh, György
TI  - Mannose-binding lectin levels and carotid intima-media thickness in type 2 diabetic patients
JF  - JOURNAL OF DIABETES RESEARCH
J2  - J DIABETES RES
VL  - 2016
PY  - 2016
SN  - 2314-6745
DO  - 10.1155/2016/8132925
UR  - https://m2.mtmt.hu/api/publication/2959691
ID  - 2959691
N1  - Összes idézések száma a WoS-ban: 0
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Ilonczai, Péter
AU  - Oláh, Zsolt
AU  - Selmeczi, A
AU  - Kerenyi, Adrienne
AU  - Bereczky, Zsuzsanna
AU  - Póka, Róbert
AU  - Schlammadinger, Ágota
AU  - Boda, Zoltán
TI  - Management and outcome of pregnancies in women with antithrombin deficiency: a single-center experience and review of literature
JF  - BLOOD COAGULATION & FIBRINOLYSIS
J2  - BLOOD COAGUL FIBRIN
VL  - 26
PY  - 2015
IS  - 7
SP  - 798
EP  - 804
PG  - 7
SN  - 0957-5235
DO  - 10.1097/MBC.0000000000000348
UR  - https://m2.mtmt.hu/api/publication/2980920
ID  - 2980920
AB  - Women with antithrombin (AT) deficiency have an increased risk for pregnancy-associated venous thromboembolism (VTE) and adverse pregnancy outcome. AT deficiency is a rare thrombophilia with heterogeneous genetic background. Owing to the few cases reported in the literature, management strategies of pregnancy with AT deficiency are inconsistent. Our aim was to examine the type of the genetic defect, management, maternal, and pregnancy outcome in patients with hereditary AT deficiency. Five expectant mothers with AT deficiency were followed in our center to evaluate thrombotic events, and maternal and pregnancy outcomes. AT gene sequencing was performed in all cases, and levels of AT and anti-activated factor X were regularly measured to guide the risk-adopted anticoagulant prophylaxis. Three mothers had homozygous type II heparin-binding site mutations and two had heterozygous type I mutations of the gene encoding AT. Two women had additional factor V Leiden heterozygous mutations. Three maternal VTEs - four healthy newborns and five pregnancy losses - were observed. The risk of patients to VTE and adverse pregnancy outcome was found to associate with the homozygous type II heparin-binding site mutation of the AT gene. High risk of maternal VTE and frequent pregnancy complications were observed to associate with AT deficiency. Our results support the need of individualized, risk-adopted anticoagulant therapy in patients with AT deficiency.
LA  - English
DB  - MTMT
ER  - 

TY  - CHAP
AU  - Bereczky, Zsuzsanna
ED  - Oláh, Éva
TI  - A véralvadás genetikai eredetű zavarai
T2  - Klinikai genetika
PB  - Medicina Könyvkiadó
CY  - Budapest
SN  - 9789632265407
PY  - 2015
SP  - 487
EP  - 500
PG  - 14
UR  - https://m2.mtmt.hu/api/publication/2956641
ID  - 2956641
LA  - Hungarian
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Árokszállási, Anita
AU  - Kerenyi, Adrienne
AU  - Katona, Éva
AU  - Bereczky, Zsuzsanna
AU  - Muszbek, László
AU  - Boda, Zoltán
AU  - Schlammadinger, Ágota
TI  - The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency - the first experience.
JF  - HAEMOPHILIA
J2  - HAEMOPHILIA
VL  - 21
PY  - 2015
IS  - 1
SP  - e118
EP  - e121
SN  - 1351-8216
DO  - 10.1111/hae.12591
UR  - https://m2.mtmt.hu/api/publication/2810030
ID  - 2810030
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Kovács, Bernadett
AU  - Pataki, István
AU  - Bárdos, Helga
AU  - Pfliegler, György
AU  - Komáromi, István
AU  - Fekete, Adrienn
AU  - Haramura, Gizella
AU  - Ádány, Róza
AU  - Balla, György
AU  - Muszbek, László
AU  - Bereczky, Zsuzsanna
TI  - Molecular Characterization of Novel Protein C Mutations (p.Asp77Gly, p.Ala163Val and p.Ala163Glu) Causing Protein C Deficiency
JF  - THROMBOSIS RESEARCH
J2  - THROMB RES
VL  - 133
PY  - 2014
IS  - S3
SP  - S11
EP  - S11
PG  - 1
SN  - 0049-3848
DO  - 10.1016/S0049-3848(14)50061-8
UR  - https://m2.mtmt.hu/api/publication/2942958
ID  - 2942958
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Gindele, Réka
AU  - Speker, Marianna
AU  - Udvari, Á
AU  - Oláh, Zsolt
AU  - Pfliegler, György
AU  - Schlammadinger, Á
AU  - Rázsó, K
AU  - Marján, E
AU  - Losonczy, Hajna
AU  - Selmeczi, A
AU  - Boda, Zoltán
AU  - Muszbek, L
AU  - Bereczky, Zsuzsanna
TI  - High prevalence of antithrombin Budapest 3 mutation in Hungary, investigation of founder effect
JF  - THROMBOSIS RESEARCH
J2  - THROMB RES
VL  - 133
PY  - 2014
IS  - S3
SP  - S11
EP  - S12
SN  - 0049-3848
UR  - https://m2.mtmt.hu/api/publication/2826637
ID  - 2826637
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Miklós, T
AU  - Oláh, Zsolt
AU  - Schlammadinger, Á
AU  - Ilonczai, P
AU  - Pfliegler, G
AU  - Boda, Zoltán
AU  - Kovács, KB
AU  - Gindele, Réka
AU  - Szabó, Z
AU  - Kerenyi, Adrienne
AU  - Muszbek, L
AU  - Bereczky, Zsuzsanna
TI  - Diagnostic considerations based on the experience of genetic analysis in Protein S deficiency in the Hungarian population with high frequency of FV Leiden mutation
JF  - THROMBOSIS RESEARCH
J2  - THROMB RES
VL  - 133
PY  - 2014
IS  - S3
SP  - S81
EP  - S81
SN  - 0049-3848
UR  - https://m2.mtmt.hu/api/publication/2826610
ID  - 2826610
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Udvari, Á
AU  - Speker, Marianna
AU  - Gindele, Réka
AU  - Balogh, László
AU  - Mezei, Zoltán András
AU  - Kerenyi, Adrienne
AU  - Bagoly, Zsuzsa
AU  - Kiss, C
AU  - Muszbek, László
AU  - Bereczky, Zsuzsanna
TI  - Antitrombin Cambridge II és Budapest 3 mutációk vizsgálata artériás érbetegségekben és gyermekkori vénás trombózisban
JF  - METABOLIZMUS
J2  - METABOLIZMUS
VL  - 12
PY  - 2014
IS  - 4
SP  - 262
EP  - 263
PG  - 2
SN  - 1589-7311
UR  - https://m2.mtmt.hu/api/publication/2817179
ID  - 2817179
LA  - Hungarian
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Speker, Marianna
AU  - Udvari, Á
AU  - Gindele, Réka
AU  - Selmeczi, A
AU  - Oláh, Zsolt
AU  - Schlammadinger, Á
AU  - Rázsó, Katalin
AU  - Ilonczai, P
AU  - Marján, E
AU  - Boda, Zoltán
AU  - Pfliegler, G
AU  - Muszbek, L
AU  - Bereczky, Zsuzsanna
TI  - Antitrombin Budapest 3 mutáció alapító hatásának igazolása genetikai markerekkel a magyarországi thrombophiliás populációban
JF  - METABOLIZMUS
J2  - METABOLIZMUS
VL  - 12
PY  - 2014
IS  - 4
SP  - 261
EP  - 261
PG  - 1
SN  - 1589-7311
UR  - https://m2.mtmt.hu/api/publication/2817170
ID  - 2817170
LA  - Hungarian
DB  - MTMT
ER  -